BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  Obsidian Therapeutics Announces $49.5M Million Series A Financing to Develop Controllable Cell and Gene Therapy Products

  Obsidian today announced the completion of a $49.5M Series A financing to further build its technology platform and advance its lead programs toward clinical development.

  December 6, 2017

   · 

  5 min read
• The University of Nantes Faculty of Science & Technology Uses the Magritek Spinsolve Benchtop NMR System in the Development of New Methods Such as the Implementation of Ultrafast Quantitative 2D NMR.

  Magritek reports on the R&D work of Professor Patrick Giraudeau and his group at the University of Nantes.

  December 6, 2017

   · 

  5 min read
• Pharm Country

  Children’s Hospital of Philadelphia Release: Brain Remaps Itself in Child With Double Hand Transplant

  The first child to undergo a successful hand transplant also is the first child in whom scientists have detected massive changes in how sensations from the hands are represented in the brain.

  December 6, 2017

   · 

  6 min read
• Tetra Bio-Pharma Opens Markets at TSX Listing Ceremony

  The listing ceremony took place at the TMX Broadcast Centre in Toronto, Ontario. Bernard Fortier, Chief Executive Officer (CEO), and Bernard Lessard, Chief Financial Officer, represented Tetra at the listing ceremony.

  December 6, 2017

   · 

  5 min read
• Synaffix Launches toxSYN, a New Platform of ADC Payloads

  Synaffix launch of a new platform of highly potent cytotoxic ADC payloads that will be integrated into its existing ADC platform.

  December 6, 2017

   · 

  3 min read
• Biotech Beach

  Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 San Antonio Breast Cancer Symposium

  The presentation entitled, “Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2-positive early stage breast cancer: the CONTROL trial,” will be presented at a poster session on December 7 at 5:00 p.m. CST.

  December 6, 2017

   · 

  11 min read
• EOS imaging Awarded the Prix Galien in the Medical Device Category

  The award is presented to EOS imaging in recognition of its EOS system for 2D/3D low dose imaging and associated EOSapps suite of online 3D surgical planning solutions for spine, hip and knee surgeries.

  December 6, 2017

   · 

  2 min read
• Business

  CVD Completes Purchase of 180,000 Sq. Ft. Facility

  This new facility will be the primary manufacturing center for the Company’s wholly owned subsidiary, CVD Materials Corporation.

  December 6, 2017

   · 

  3 min read
• Rhythmlink Launches FDA Cleared MR Conditional*/CT Quick Connect System Product Line

  Rhythmlink announced the release of a new product line designed to maximize efficiency and workflow when recording EEG on patients who require MR or CT imaging.

  December 6, 2017

   · 

  4 min read
• 

  Deals

  Edwards Lifescience Scoops Up Harpoon Medical for $100M

  In addition, there is the potential for up to $150 million in pre-specified milestone-driven payments over the next 10 years.

  December 6, 2017

   · 

  4 min read